Ameriprise’s IDENIX PHARMACEUTICALS INC IDIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
Sell
-721
Closed -$17K 6051
2014
Q2
$17K Sell
721
-439
-38% -$4.58K ﹤0.01% 4424
2014
Q1
$7K Buy
1,160
+650
+127% +$4.53K ﹤0.01% 4703
2013
Q4
$3K Sell
510
-5,799
-92% -$26.8K ﹤0.01% 4817
2013
Q3
$32K Sell
6,309
-104
-2% -$456 ﹤0.01% 4094
2013
Q2
$22K Buy
+6,413
New +$26.2K ﹤0.01% 4224

Ameriprise's IDIX Position: Q3 2014 in Review

Ameriprise sold out of IDENIX PHARMACEUTICALS INC (IDIX) in Q3 2014, closing a stake of 721 shares — an estimated $17K sold.

Ameriprise first reported a position in IDIX in Q2 2013 and held it in 5 quarters. The position peaked at $32K in Q3 2013. 0 funds tracked by Wall St. Rank hold IDIX as of Q3 2014.

  • Ameriprise reported no remaining IDENIX PHARMACEUTICALS INC position as of Q3 2014 after selling out during the quarter.
  • Ameriprise sold 721 IDENIX PHARMACEUTICALS INC shares in Q3 2014, an estimated $17K.
  • Ameriprise first reported a position in IDENIX PHARMACEUTICALS INC in Q2 2013 and held it in 5 quarters.
  • Ameriprise's IDENIX PHARMACEUTICALS INC position peaked at $32K in Q3 2013.
  • 0 funds tracked by Wall St. Rank held IDENIX PHARMACEUTICALS INC as of Q3 2014.

Based on Ameriprise's 13F filing for Q3 2014, filed 14 Nov 2014.